Please login to the form below

Not currently logged in
Email:
Password:

Genzyme

This page shows the latest Genzyme news and features for those working in and with pharma, biotech and healthcare.

VCCP Health lands record haul at the PM Society Awards

VCCP Health lands record haul at the PM Society Awards

Target Award for Corporate Communications - H4B Manchester for Sanofi Genzyme.

Latest news

  • Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

    For Sanofi it is the biggest acquisition since buying rare disease specialist Genzyme for $20bn in 2011, coming after it lost out to Pfizer in a contest to buy cancer specialist

  • NICE backs Sanofi's Kevzara for routine NHS use NICE backs Sanofi's Kevzara for routine NHS use

    Peter Kuiper, Sanofi Genzyme ’s general manager for UK and Ireland, said: “This recommendation brings us one step closer to making Kevzara available to adult patients with severe RA and reinforces

  • Sanofi Genzyme brings The World Vs MS to Denmark Sanofi Genzyme brings The World Vs MS to Denmark

    Sanofi Genzyme brings The World Vs MS to Denmark. Firm's Comm uniqué Award winning campaign launches in another local market. ... Sanofi’s Genzyme unit has brought the global The World Vs MS campaign to its latest local market, launching it in Denmark.

  • Solid start for Dupixent as Sanofi raises 2017 outlook Solid start for Dupixent as Sanofi raises 2017 outlook

    All told, Sanofi reported a 6% increase in sales in the second quarter to 8.66bn, with buoyant growth at Sanofi's rare disease unit Genzyme and vaccines subsidiary Sanofi Pasteur ... Chief executive Olivier Brandicourt said that the gains for Genzyme and

  • McCann Health cleans up at The Creative Floor Awards 2017 McCann Health cleans up at The Creative Floor Awards 2017

    Additionally, the Sanofi Genzyme Europe MS Team was revealed as the Bravest Client, alongside Meta Mucil’s Akhilesh Negi, Andrew Crowe and Nitin Darbari. ... FCB Health. AMV BBDO. The Bloc. Havas Lynx. Sanofi Genzyme Europe MS.

More from news
Approximately 28 fully matching, plus 171 partially matching documents found.

Latest Intelligence

  • Pharma deals in July 2015 Pharma deals in July 2015

    Firstly the divestment for up to $300m to Genzyme of Caprelsa (vandetanib), an orphan drug treatment for thyroid carcinoma. ... 560+. AstraZeneca / Genzyme. Acquisition of R&D. Caprelsa (vandetanib) marketed. 300.

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Voyager Therapeutics/ Sanofi (Genzyme). Gene therapy - Parkinson's disease, Friedreich's ataxia and Huntington's disease.

  • Pharma deals during November 2014 Pharma deals during November 2014

    Cerdelga, an oral therapy for adult patients with Gaucher disease type 1, was developed by Genzyme and approved by the FDA in August this year.

  • Pharma deals during January 2014 Pharma deals during January 2014

    The now expanded deal grants Genzyme rights in all markets outside North America and Western Europe. ... In 2008 Genzyme gained rights to ataluren from PTC Therapeutics at a cost of $100m.

  • Deal Watch table for January 2014 Deal Watch table for January 2014

    Alnylam/ Genzyme. Extended agreement. Additional markets for patisiran and 3 pipeline products with option to all rare disease products.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 4 fully matching, plus 34 partially matching documents found.

Latest from PMHub

  • Lucid Group make the cut at the PMEAs 2017

    OptiMiSe: a Multichannel Learning Platform for Clinical Behaviour Change Among Multiple Sclerosis Specialist Nurses, by Sanofi Genzyme, with support from Lucid Group.

  • Frontera

    Galderma. Novartis. Grunenthal. Genzyme. Quit. Pfizer. Pathway. Vertex. Beating Bowl Cancer.

  • Lucid celebrate big wins at PMEA 2015

    Lucid group successfully supported AbbVie and Genzyme to win two awards at last night’ s ceremony in London. ... And they celebrated with Genzyme after supporting them to win the award for launch excellence.

  • Lucid Group Communications Limited

    Celgene. CSL Behring. Eisai. Ferring Pharmaceuticals Ltd. Genzyme. Gilead. GlaxoSmithKline. Janssen.

  • HAVAS LYNX

    AbbVie. Alexion. Almirall. Astellas. AstraZeneca. Bayer. Eisai. Genzyme. Janssen. Kowa. Lilly.

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics